IP Library Granted Patent US 10,173,062
Granted Patent B2
US 10,173,062 · App. 15/227,821 · Granted Jan 8, 2019

Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods

Inventor: Jon Parker (San Jose, CA)
Assignee: Nevro Corp.
A61N1/36071A61N1/36125A61N1/36171A61N1/36175A61N1/3708
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,173,062
App. No.
15/227,821
Granted
Jan 8, 2019
Kind
B2
Abstract

Implanted pulse generators with reduced power consumption via signal strength-duration characteristics, and associated systems and methods are disclosed. A representative method for treating a patient in accordance with the disclosed technology includes receiving an input corresponding to an available voltage for an implanted medical device and identifying a signal delivery parameter value of an electrical signal based on a correlation between values of the signal delivery parameter and signal deliver amplitudes. The signal deliver parameter can include at least one of pulse width or duty cycle. The method can further include delivering an electrical therapy signal to the patient at the identified signal delivery parameter value using a voltage within a margin of the available voltage.

Claims (60)

1. A patient therapy system, comprising:

a pulse generator configured to deliver electrical therapy to a patient; and

a processor operatively coupled to the pulse generator and configured to:

receive an input corresponding to an available voltage for the pulse generator;

identify a value of a signal delivery parameter of an electrical therapy signal based on a correlation between values of signal delivery amplitudes and (a) pulse width, (b) duty cycle, or (c) pulse width and duty cycle, wherein the identified signal delivery parameter value is increased in response to a decrease in available voltage; and

direct the pulse generator to deliver the electrical therapy signal at the identified signal delivery parameter value using a voltage within a margin of the available voltage.

2. The system of claim 1 wherein the electrical therapy signal has a frequency of from 1.5 kHz to 100 kHz.

3. The system of claim 1 wherein the signal delivery parameter is pulse width.

4. The system of claim 1 wherein the signal delivery parameter is duty cycle.

5. The system of claim 1 wherein the available voltage is an output voltage of a battery that provides power for the electrical therapy signal.

6. The system of claim 1 , further comprising a signal delivery element coupled to the pulse generator to deliver the electrical therapy signal to a patient.

7. The system of claim 1 wherein the processor and the pulse generator are housed in a patient-implantable device.

8. The system of claim 1 wherein the pulse generator is housed in a patient-implantable device, and the processor is housed in an external device.

9. The system of claim 1 wherein the pulse generator is configured to deliver the electrical therapy signal at a pulse width of from 10 microseconds to 333 microseconds.

10. The system of claim 1 wherein the processor is further configured to:

receive at least one input corresponding to a target therapy amplitude and a target pulse width;

determine that the available voltage is insufficient to deliver the electrical therapy signal at the target therapy amplitude and the target pulse width; and

identify an updated therapy amplitude less than the target therapy amplitude,

wherein identifying the signal delivery parameter value includes identifying an updated pulse width greater than the target pulse width.

11. The system of claim 10 wherein the processor is further configured to:

determine if the updated pulse width can be delivered at a target frequency; and

if the updated pulse width cannot be delivered at the target frequency, update the target frequency.

12. The system of claim 1 wherein the identified signal delivery parameter value includes a pulse width value.

13. The system of claim 1 wherein the identified signal delivery parameter value includes a duty cycle value.

14. A patient therapy system, comprising:

a pulse generator configured to deliver electrical therapy to a patient at a frequency of from 1.5 kHz to 100 kHz; and

a processor operatively coupled to the pulse generator and configured to:

receive an input corresponding to an available voltage for the pulse generator;

identify a signal delivery parameter value of an electrical therapy signal based on a correlation between values of the signal delivery parameter and signal delivery amplitudes, wherein the signal delivery parameter includes at least one of pulse width or duty cycle; and

direct the pulse generator to deliver the electrical therapy signal at the identified signal delivery parameter value using a voltage within a margin of the available voltage.

15. The system of claim 14 wherein the signal delivery parameter is pulse width.

16. The system of claim 14 wherein the signal delivery parameter is duty cycle.

17. The system of claim 14 wherein the available voltage is an output voltage of a battery that provides power for the electrical therapy signal.

18. The system of claim 14 , further comprising a signal delivery element coupled to the pulse generator to deliver the electrical therapy signal to a patient.

19. The system of claim 14 wherein the processor and the pulse generator are housed in a patient-implantable device.

20. The system of claim 14 wherein the pulse generator is housed in a patient-implantable device, and the processor is housed in an external device.

21. The system of claim 14 wherein the pulse generator is configured to deliver the electrical therapy signal at a pulse width of from 10 microseconds to 333 microseconds.

22. The system of claim 14 wherein the processor is programmed with instructions that, when executed:

receive at least one input corresponding to a target therapy amplitude and a target pulse width;

determine that the available voltage is insufficient to deliver the electrical therapy signal at the target therapy amplitude and the target pulse width; and

identify an updated therapy amplitude less than the target therapy amplitude,

wherein identifying the signal delivery parameter value includes identifying an updated pulse width greater than the target pulse width.

23. The system of claim 22 wherein the instructions, when executed:

determine if the updated pulse width can be delivered at a target frequency; and

if the updated pulse width cannot be delivered at the target frequency, update the target frequency.

24. A method for treating a patient, comprising:

configuring a pulse generator to:

receive an input corresponding to an available voltage for an implanted medical device;

identify a signal delivery parameter value of an electrical therapy signal based on a correlation between values of signal delivery amplitudes and at least one of pulse width or duty cycle, wherein the identified signal delivery parameter value is increased in response to a decrease in available voltage; and

deliver the electrical therapy signal to the patient at the identified signal delivery parameter value using a voltage within a margin of the available voltage.

25. The method of claim 24 wherein the signal delivery parameter is pulse width.

26. The method of claim 24 wherein the signal delivery parameter is duty cycle.

27. The method of claim 24 wherein the available voltage is an output voltage of a battery that provides power for the electrical therapy signal.

28. The method of claim 24 wherein the pulse generator is further configured to:

receive at least one input corresponding to a target therapy amplitude and a target pulse width;

determine that the available voltage is insufficient to supply a therapy signal at the target therapy amplitude and the target pulse width; and

identify an updated therapy amplitude less than the target therapy amplitude,

wherein identifying the signal delivery parameter value includes identifying an updated pulse width greater than the target pulse width.

29. The method of claim 24 , wherein the correlation is a patient-specific correlation, and wherein the method further comprises establishing the correlation.

30. The method of claim 29 wherein establishing the correlation includes establishing the correlation by producing paresthesia in the patient, and wherein delivering the electrical therapy signal does not produce paresthesia in the patient.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA NAME PREVIOUSLY RECORDED ON REEL 039478 FRAME 0307. ASSIGNOR(S) HEREBY CONFIRMS THE RECEIVING PARTY DATA NAME IS NEVRO CORP. Recorded Jan 20, 2017
From: PARKER, JON
To: NEVRO CORP.
Reel/Frame 041453/0127 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2016
From: PARKER, JON
To: NEVRO CORPORATION
Reel/Frame 039478/0307 →
Continuity (3)
Continuation 14710375 · May 12, 2015
Provisional Application 62000985 · May 20, 2014
Related Publication 20170036023A1 · Feb 9, 2017
Cited By (11)
US 12,226,643 US 12,390,644 US 12,420,103 US 12,440,676 US 12,465,776 US 12,485,287 US 12,551,705 US 12,569,692 US 12,599,770 US 12,629,513 US 12,646,652